Using antibiotics in suspected haemolytic-uraemic syndrome

EDITOR-By uncritically quoting the meta-analysis of Safdar et al in their evidence based case report, Phillips et al perpetuate an error about antibiotic treatment of Escherichia coli O157:H7 infections. 1 2 Specifically, Safdar et al mischaracterised a study by Ikeda et al as showing that treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 2005-05, Vol.330 (7501), p.1209-1209
Hauptverfasser: Dundas, Stephanie, Todd, W. T. Andrew, Neill, Marguerite A., Tarr, Phillip I., Phillips, Bob, Tyerman, Kay, Whiteley, Simon M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:EDITOR-By uncritically quoting the meta-analysis of Safdar et al in their evidence based case report, Phillips et al perpetuate an error about antibiotic treatment of Escherichia coli O157:H7 infections. 1 2 Specifically, Safdar et al mischaracterised a study by Ikeda et al as showing that treatment of E coli O157:H7 infections with fosfomycin diminished the risk of haemolytic-uraemic syndrome compared with no antibiotic treatment. 3 However, Ikeda et al did not show that antibiotics prevent the syndrome because two of the 256 patients were not treated. [...]statistically significant benefit emerged only after subgroup analysis, with the implication that treatment had value only if started on day 2 of illness.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.330.7501.1209